Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Genetic Factors Other Than CYP2C9 and VKORC1 That Influence Warfarin Dose Requirements in a South-east Asian Population

NCT01050920 is registered in ClinicalTrials.gov with National University Hospital, Singapore as lead sponsor.

NCT NCT01050920
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01050920 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Genetic Factors Other Than CYP2C9 and VKORC1 That Influence Warfarin Dose Requirements in a South-east Asian Population
Lead sponsor
National University Hospital, Singapore
Phase
Observational
Overall status
Unknown status
Start date
September 30, 2013
Completion date
December 31, 2014
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer